Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Growth in Short Interest

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 33,900 shares, a growth of 1,312.5% from the December 15th total of 2,400 shares. Currently, 1.2% of the company’s stock are sold short. Based on an average trading volume of 1,090,000 shares, the short-interest ratio is currently 0.0 days.

Shuttle Pharmaceuticals Stock Performance

NASDAQ:SHPH traded down $0.02 during midday trading on Tuesday, hitting $0.88. The company’s stock had a trading volume of 45,843 shares, compared to its average volume of 72,365. Shuttle Pharmaceuticals has a fifty-two week low of $0.58 and a fifty-two week high of $4.95. The company’s 50 day simple moving average is $0.87. The company has a market capitalization of $3.23 million, a price-to-earnings ratio of -0.21 and a beta of -1.74.

About Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .